Biochips Market 2017 Share, Trend, Segmentation and Forecast to 2025

The Latest Comprehensive Industry research study titled, “Biochips Market by Products, Application - Global Industry Analysis and Forecast To 2025” published by Crystal Market Research, states that the fermentation chemicals market is projected to be around $ 26 billion by 2025.

The biochips market is expected to be around $26 billion by 2025. Increasing advancements in personalized medicine, rising demand for miniaturization of clinical and biological test systems, increase in research activities related to proteomics and genomics, advancements in designing protein arrays and rising applications of biochips in accelerated drug development are some of the major factors driving the growth of global biochips market. Moreover, increase in the incidence of chronic diseases such as cancer has prompted development of biochips to be used for diagnosing certain variants of these diseases and for controlling disease progression. According to the National Cancer Institute under the U.S. Department of Health and Human Services, between 2012 and 2030, new cancer cases around the world are expected to increase by 50% from 14 million to 21 million. With such high incidence of cancer, the related research efforts are expected to significantly increase thus favorably contributing to the growth of biochips market during the forecast period. However, factors such as high cost of biochip instrumentation and unclear regulatory guidelines can hamper the growth of this biochips market during the forecast period.

Get sample copy of this Report: https://www.crystalmarketresearch.com/report-sample/SE09229

Key Market Players:
Thermo Fisher Scientific Inc
Illumina Inc
PerkinElmer Inc
Agilent Technologies Inc.
Fluidigm Corporation
General Electric Company
Bio-Rad Laboratories Inc.
bioMérieux SA
Cellix Ltd.

DNA chips segment dominated the global biochips market in 2016. This market dominance can be attributed to the extensive adoption of DNA chips for detection and diagnosis of various genetic diseases along with increased focus on research related to next-generation sequencing and genomics. With rapid adoption of diagnostic lab-on-a-chip (LOAC) and DNA analysis for point-of-care diagnostics and drug discovery applications, the global biochips market will experience robust growth during the forecast period. Drug discovery and development segment held a major share of the biochips market in 2016 as biochips are being increasingly adopted for developing highly specific drug molecules and new chemical entity (NCE) drugs for the treatment of various diseases. Biochips can considerably reduce the cost of drug discovery and aid in improving drug safety and hence are being widely adopted by biotechnology and pharmaceutical companies for drug discovery applications.

Two major technologies used for fabricating biochips involve microarrays and microfluidics. A microarray is a silicon chip or a glass slide which consists of an array of molecules such as polypeptides, clones, oligonucleotides and antibodies. These molecules used are primarily used for gene expression and simultaneous examination of relationship between different genes. Microfluidics is a technology which involves micro-channels segmented on glass or a silicon substrate. This technology has various biomedical applications that include immunoassays, drug discovery, capillary electrophoresis and cell biology research.

Make Inquiry about Report: https://www.crystalmarketresearch.com/send-an-enquiry/SE09229

Market Opportunities
With high prevalence of cancer and other chronic diseases worldwide, the need for advanced drug development alternatives is increasing significantly in all parts of the world. Emerging markets such as Asia-Pacific are expected to offer significant growth opportunities for the global biochips market in coming years as expenditure on advanced research is rising considerably in developing countries such as China and India.

Biochips Market Segmentation:

By Product:
DNA Chips
Protein Chips
Lab-on-a-chip
Tissue Arrays
Cell Arrays
By Application:
Gene Expression
Genomics
SNP Genotyping
Drug Discovery & Development
Clinical Diagnostics
Cancer Diagnosis & Treatment
Proteomics
Agricultural Biotechnology
IVD and POC
High-Throughput Screening
By Fabrication Technology:
Microfluidics
Microarrays
By End User:
Academic & Research Institutes
Hospitals and Diagnostics Centers
Biotechnology and Pharmaceutical Companies

Get Customized Report and Best Discount offers for your region: https://www.crystalmarketresearch.com/customization/SE09229

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:

Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Blog: blog.crystalmarketresearch.com
Website: www.crystalmarketresearch.com

This release was published on openPR.